1.           Introduction

1.1         Scope of the Study

1.2         The Insight Partners Research Report Guidance

1.3         Market Segmentation

1.3.1        Asia Pacific Rare Neurological Disease Treatment Market – By Indication

1.3.2        Asia Pacific Rare Neurological Disease Treatment Market – By Drug Type

1.3.3        Asia Pacific Rare Neurological Disease Treatment Market – By Distribution Channel

1.3.4        Asia Pacific Rare Neurological Disease Treatment Market – By Mode of Administration

1.3.5        Asia Pacific Rare Neurological Disease Treatment Market – By Country

2.           Asia Pacific Rare Neurological Disease Treatment Market – Key Takeaways

3.           Research Methodology

3.1         Coverage

3.2         Secondary Research

3.3         Primary Research

4.           Asia Pacific Rare Neurological Disease Treatment Market – Market Landscape

4.1         Overview

4.2         PEST Analysis

4.2.1        Rare Neurological Disease Treatment Market - Asia Pacific PEST Analysis

4.3         Expert Opinion

5.           Asia Pacific Rare Neurological Disease Treatment Market - Key Market Dynamics

5.1         Key Market Drivers

5.1.1        Rising Prevalence of Rare Neurological Diseases

5.1.2        Favourable Pipeline Drugs and Robust Research Activities for the Treatment of Rare Neurological Diseases

5.2         Key Restraints

5.2.1        High Treatment Cost for Rare Neurological Diseases

5.3         Key Market Opportunities

5.3.1        Increasing Awareness of Rare Neurological Diseases Coupled with Developing Healthcare Infrastructure

5.4         Future Trend

5.4.1        Artificial Intelligence for the Treatment of Rare Neurological Diseases

5.5         Impact Analysis

6.           Rare Neurological Disease Treatment Market –  Asia Pacific Analysis

6.1         Asia Pacific Rare Neurological Disease Treatment Market Revenue Forecasts and Analysis

7.           Asia Pacific Rare Neurological Disease Treatment Market Analysis and Forecasts To 2027 –  By Indication

7.1         Overview

7.2         Asia Pacific Rare Neurological Disease Treatment Market, By Indication 2019 & 2027 (%)

7.2.1        Asia Pacific Rare Neurological Disease Treatment Market Revenue and Forecasts to 2027, By Indication (US$ Mn)

7.3         Narcolepsy

7.3.1        Overview

7.3.2        Asia Pacific Narcolepsy Market Revenue and Forecast to 2027 (US$ Mn)

7.4         Amyotrophic Lateral Sclerosis

7.4.1        Overview

7.4.2        Asia Pacific Amyotrophic Lateral Sclerosis Market Revenue and Forecast to 2027 (US$ Mn)

7.5         Alzheimer’s Disease

7.5.1        Overview

7.5.2        Asia Pacific Alzheimer’s Disease Market Revenue and Forecast to 2027 (US$ Mn)

7.6         Multiple Sclerosis

7.6.1        Overview

7.6.2        Asia Pacific Multiple Sclerosis Market Revenue and Forecast to 2027 (US$ Mn)

7.7         Spinal Muscular Atrophy (SMA)

7.7.1        Overview

7.7.2        Asia Pacific Spinal Muscular Atrophy Market Revenue and Forecast to 2027 (US$ Mn)

7.8         Duchenne Muscular Dystrophy

7.8.1        Overview

7.8.2        Asia Pacific Duchenne Muscular Dystrophy Market Revenue and Forecast to 2027 (US$ Mn)

7.9         Other Indications

7.9.1        Overview

7.9.2        Asia Pacific Other Indications Market Revenue and Forecast to 2027 (US$ Mn)

8.           Asia Pacific Rare Neurological Disease Treatment Market Analysis– By Drug Type

8.1         Overview

8.2         Asia Pacific Rare Neurological Disease Treatment Market, By Drug Type 2019-2027 (%)

8.2.1        Asia Pacific Rare Neurological Disease Treatment Market Revenue and Forecasts to 2027, By Drug Type (US$ Mn)

8.3         Organic Compounds

8.3.1        Overview

8.3.2        Asia Pacific Organic Compounds Market Revenue and Forecasts to 2027 (US$ Mn)

8.4         Biologics

8.4.1        Overview

8.4.2        Asia Pacific Biologics Market Revenue and Forecasts to 2027 (US$ Mn)

9.           Asia Pacific Rare Neurological Disease Treatment Market Analysis– By Distribution Channel

9.1         Overview

9.2         Asia Pacific Rare Neurological Disease Treatment Market, By Distribution Channel 2019 & 2027 (%)

9.2.1        Asia Pacific Rare Neurological Disease Treatment Market Revenue and Forecasts to 2027, By Distribution Channel (US$ Mn)

9.3         Online Pharmacies

9.3.1        Overview

9.3.2        Asia Pacific Online Pharmacies Market Revenue and Forecast to 2027 (US$ Mn)

9.4         Hospital Pharmacies

9.4.1        Overview

9.4.2        Asia Pacific Hospital Pharmacies Market Revenue and Forecasts to 2027 (US$ Mn)

9.5         Retail Pharmacies

9.5.1        Overview

9.5.2        Asia Pacific Retail Pharmacies Market Revenue and Forecasts to 2027 (US$ Mn)

10.        Asia Pacific Rare Neurological Disease Treatment Market Analysis– By Mode of Administration

10.1      Overview

10.2      Asia Pacific Rare Neurological Disease Treatment Market, By Mode of Administration 2019 & 2027 (%)

10.2.1     Asia Pacific Rare Neurological Disease Treatment Market Revenue and Forecasts to 2027, By Mode of Administration (US$ Mn)

10.3      Oral

10.3.1     Overview

10.3.2     Asia Pacific Oral Market Revenue and Forecast to 2027 (US$ Mn)

10.4      Injectable

10.4.1     Overview

10.4.2     Asia Pacific Injectable Market Revenue and Forecasts to 2027 (US$ Mn)

11.        Rare Neurological Disease Treatment Market Revenue and Forecasts To 2027 – Geographical Analysis

11.1      Asia Pacific Rare Neurological Disease Treatment Market Revenue and Forecasts To 2027

11.1.1     Overview

11.1.2     Asia Pacific: Rare Neurological Disease Treatment Market - Revenue and Forecast to 2027 (USD Million)

11.1.3     Asia Pacific: Rare Neurological Disease Treatment Market, by Indication, 2018–2027 (USD Million)

11.1.4     Asia Pacific: Rare Neurological Disease Treatment Market, by Drug Type, 2018–2027 (USD Million)

11.1.5     Asia Pacific: Rare Neurological Disease Treatment Market, by Mode of Administration, 2018–2027 (USD Million)

11.1.6     Asia Pacific: Rare Neurological Disease Treatment Market, by Distribution Channel, 2018–2027 (USD Million)

11.1.7     Asia Pacific: Rare Neurological Disease Treatment Market, by Country, 2019& 2027 (%)

11.1.8     China: Rare Neurological Disease Treatment Market – Revenue and Forecast to 2027 (USD Million)

11.1.8.1       China: Rare Neurological Disease Treatment Market – Revenue and Forecast to 2027 (USD Million)

11.1.8.2       China: Rare Neurological Disease Treatment Market, by Indication, 2018–2027 (USD Million)

11.1.8.3       China: Rare Neurological Disease Treatment Market, by Drug Type, 2018–2027 (USD Million)

11.1.8.4       China: Rare Neurological Disease Treatment Market, by Mode of Administration, 2018–2027 (USD Million)

11.1.8.5       China: Rare Neurological Disease Treatment Market, by Distribution Channel, 2018–2027 (USD Million)

11.1.9     Japan: Rare Neurological Disease Treatment Market – Revenue and Forecast to 2027 (USD Million)

11.1.9.1       Japan: Rare Neurological Disease Treatment Market – Revenue and Forecast to 2027 (USD Million)

11.1.9.2       Japan: Rare Neurological Disease Treatment Market, by Indication, 2018–2027 (USD Million)

11.1.9.3       Japan: Rare Neurological Disease Treatment Market, by Drug Type, 2018–2027 (USD Million)

11.1.9.4       Japan: Rare Neurological Disease Treatment Market, by Mode of Administration, 2018–2027 (USD Million)

11.1.9.5       Japan: Rare Neurological Disease Treatment Market, by Distribution Channel, 2018–2027 (USD Million)

11.1.10  India: Rare Neurological Disease Treatment Market – Revenue and Forecast to 2027 (USD Million)

11.1.10.1    India: Rare Neurological Disease Treatment Market – Revenue and Forecast to 2027 (USD Million)

11.1.10.2    India: Rare Neurological Disease Treatment Market, by Indication, 2018–2027 (USD Million)

11.1.10.3    India: Rare Neurological Disease Treatment Market, by Drug Type, 2018–2027 (USD Million)

11.1.10.4    India: Rare Neurological Disease Treatment Market, by Mode of Administration, 2018–2027 (USD Million)

11.1.10.5    India: Rare Neurological Disease Treatment Market, by Distribution Channel, 2018–2027 (USD Million)

11.1.11  South Korea: Rare Neurological Disease Treatment Market – Revenue and Forecast to 2027 (USD Million)

11.1.11.1    South Korea: Rare Neurological Disease Treatment Market – Revenue and Forecast to 2027 (USD Million)

11.1.11.2    South Korea: Rare Neurological Disease Treatment Market, by Indication, 2018–2027 (USD Million)

11.1.11.3    South Korea: Rare Neurological Disease Treatment Market, by Drug Type, 2018–2027 (USD Million)

11.1.11.4    South Korea: Rare Neurological Disease Treatment Market, by Mode of Administration, 2018–2027 (USD Million)

11.1.11.5    South Korea: Rare Neurological Disease Treatment Market, by Distribution Channel, 2018–2027 (USD Million)

11.1.12  Australia: Rare Neurological Disease Treatment Market – Revenue and Forecast to 2027 (USD Million)

11.1.12.1    Australia: Rare Neurological Disease Treatment Market, by Indication, 2018–2027 (USD Million)

11.1.12.2    Australia: Rare Neurological Disease Treatment Market, by Drug Type, 2018–2027 (USD Million)

11.1.12.3    Australia: Rare Neurological Disease Treatment Market, by Mode of Administration, 2018–2027 (USD Million)

11.1.12.4    Australia: Rare Neurological Disease Treatment Market, by Distribution Channel, 2018–2027 (USD Million)

12.        Impact Of COVID-19 Pandemic On Global Rare Neurological Diseases Treatment Market

12.1      Asia-Pacific: Impact Assessment of COVID-19 Pandemic

13.        Asia Pacific Rare Neurological Disease Treatment Market Industry Landscape

13.1      Overview

13.2      Organic Growth Strategies

13.2.1     Overview

14.        Company Profiles

14.1      Takeda Pharmaceutical Company Limited

14.1.1     Key Facts

14.1.2     Business Description

14.1.3     Products and Services

14.1.4     Financial Overview

14.1.5     SWOT Analysis

14.1.6     Key Developments

14.2      Bayer AG

14.2.1     Key Facts

14.2.2     Business Description

14.2.3     Products and Services

14.2.4     Financial Overview

14.2.5     SWOT Analysis

14.2.6     Key Developments

14.3      Johnson & Johnson Services, Inc.

14.3.1     Key Facts

14.3.2     Business Description

14.3.3     Products and Services

14.3.4     Financial Overview

14.3.5     SWOT Analysis

14.3.6     Key Developments

14.4      Novartis AG

14.4.1     Key Facts

14.4.2     Business Description

14.4.3     Products and Services

14.4.4     Financial Overview

14.4.5     SWOT Analysis

14.4.6     Key Developments

14.5      Pfizer Inc.

14.5.1     Key Facts

14.5.2     Business Description

14.5.3     Products and Services

14.5.4     Financial Overview

14.5.5     SWOT Analysis

14.5.6     Key Developments

15.        Appendix

15.1      About The Insight Partners

15.2      Glossary of Terms

LIST OF TABLES

Table 1.             Asia Pacific Rare Neurological Disease Treatment Market Revenue and Forecasts To 2027, By Indication (US$ Mn)

Table 2.             Asia Pacific Rare Neurological Disease Treatment Market Revenue and Forecasts To 2027, By Drug Type (US$ Mn)

Table 3.             Asia Pacific Rare Neurological Disease Treatment Market Revenue and Forecasts To 2027, By Distribution Channel (US$ Mn)

Table 4.             Asia Pacific Rare Neurological Disease Treatment Market Revenue and Forecasts To 2027, By Mode of Administration (US$ Mn)

Table 5.             Asia Pacific Rare Neurological Disease Treatment Market, by Indication – Revenue and Forecast to 2027 (USD Million)

Table 6.             Asia Pacific Rare Neurological Disease Treatment Market, by Drug Type – Revenue and Forecast to 2027 (USD Million)

Table 7.             Asia Pacific Rare Neurological Disease Treatment Market, by Mode of Administration – Revenue and Forecast to 2027 (USD Million)

Table 8.             Asia Pacific Rare Neurological Disease Treatment Market, by Distribution Channel – Revenue and Forecast to 2027 (USD Million)

Table 9.             China Rare Neurological Disease Treatment Market, by Indication – Revenue and Forecast to 2027 (USD Million)

Table 10.          China Rare Neurological Disease Treatment Market, by Drug Type – Revenue and Forecast to 2027 (USD Million)

Table 11.          China Rare Neurological Disease Treatment Market, by Mode of Administration – Revenue and Forecast to 2027 (USD Million)

Table 12.          China Rare Neurological Disease Treatment Market, by Distribution Channel – Revenue and Forecast to 2027 (USD Million)

Table 13.          Japan Rare Neurological Disease Treatment Market, by Indication – Revenue and Forecast to 2027 (USD Million)

Table 14.          Japan Rare Neurological Disease Treatment Market, by Drug Type – Revenue and Forecast to 2027 (USD Million)

Table 15.          Japan Rare Neurological Disease Treatment Market, by Mode of Administration – Revenue and Forecast to 2027 (USD Million)

Table 16.          Japan Rare Neurological Disease Treatment Market, by Distribution Channel – Revenue and Forecast to 2027 (USD Million)

Table 17.          India Rare Neurological Disease Treatment Market, by Indication – Revenue and Forecast to 2027 (USD Million)

Table 18.          India Rare Neurological Disease Treatment Market, by Drug Type – Revenue and Forecast to 2027 (USD Million)

Table 19.          India Rare Neurological Disease Treatment Market, by Mode of Administration – Revenue and Forecast to 2027 (USD Million)

Table 20.          India Rare Neurological Disease Treatment Market, by Distribution Channel – Revenue and Forecast to 2027 (USD Million)

Table 21.          South Korea Rare Neurological Disease Treatment Market, by Indication – Revenue and Forecast to 2027 (USD Million)

Table 22.          South Korea Rare Neurological Disease Treatment Market, by Drug Type – Revenue and Forecast to 2027 (USD Million)

Table 23.          South Korea Rare Neurological Disease Treatment Market, by Mode of Administration – Revenue and Forecast to 2027 (USD Million)

Table 24.          South Korea Rare Neurological Disease Treatment Market, by Distribution Channel – Revenue and Forecast to 2027 (USD Million)

Table 25.          Australia Rare Neurological Disease Treatment Market, by Indication – Revenue and Forecast to 2027 (USD Million)

Table 26.          Australia Rare Neurological Disease Treatment Market, by Drug Type – Revenue and Forecast to 2027 (USD Million)

Table 27.          Australia Rare Neurological Disease Treatment Market, by Mode of Administration – Revenue and Forecast to 2027 (USD Million)

Table 28.          Australia Rare Neurological Disease Treatment Market, by Distribution Channel – Revenue and Forecast to 2027 (USD Million)

Table 29.          Recent Inorganic Growth Strategies In The Rare Neurological Disease Treatment Market

Table 30.          Recent Organic Growth Strategies In The Rare Neurological Disease Treatment Market

Table 31.          Glossary of Terms, Rare Neurological Disease Treatment Market

LIST OF FIGURES

Figure 1.           Rare Neurological Disease Treatment Market Segmentation

Figure 2.           Asia Pacific Rare Neurological Disease Treatment Market Overview

Figure 3.           Alzheimer’s Disease Segment Held Largest Share of Indication Segment in Rare Neurological Disease Treatment Market

Figure 4.           China Is Expected To Show Remarkable Growth During The Forecast Period

Figure 5.           Asia Pacific Rare Neurological Disease Treatment Market- Leading Country Markets (US$ Mn)

Figure 6.           Rare Neurological Disease Treatment Market, Industry Landscape

Figure 7.           Rare Neurological Disease Treatment Market - Asia Pacific PEST Analysis

Figure 8.           Rare Neurological Disease Treatment Market Impact Analysis of Drivers and Restraints

Figure 9.           Asia Pacific Rare Neurological Disease Treatment Market – Revenue Forecasts and Analysis – 2019- 2027

Figure 10.        Asia Pacific Rare neurological disease treatment Market, By Indication 2019 & 2027 (%)

Figure 11.        Asia Pacific Narcolepsy Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 12.        Asia Pacific Amyotrophic Lateral Sclerosis Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 13.        Asia Pacific Alzheimer’s Disease Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 14.        Asia Pacific Multiple Sclerosis Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 15.        Asia Pacific Spinal Muscular Atrophy Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 16.        Asia Pacific Duchenne Muscular Dystrophy Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 17.        Asia Pacific Other Indications Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 18.        Asia Pacific Rare Neurological Disease Treatment Market, by Drug Type 2019 & 2027 (%)

Figure 19.        Asia Pacific Organic Compounds Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 20.        Asia Pacific Biologics Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 21.        Asia Pacific Rare Neurological Disease Treatment Market, By Distribution Channel 2019 & 2027 (%)

Figure 22.        Asia Pacific Online Pharmacies Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 23.        Asia Pacific Hospital Pharmacies Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 24.        Asia Pacific Retail Pharmacies Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 25.        Asia Pacific Rare Neurological Disease Treatment Market, By Mode of Administration 2019 & 2027 (%)

Figure 26.        Asia Pacific Oral Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 27.        Asia Pacific Injectable Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 28.        Asia Pacific: Rare Neurological Disease Treatment Market, by Key Country – Revenue (2019) (USD Million)

Figure 29.        Asia Pacific Rare Neurological Disease Treatment Market Revenue and Forecast to 2027 (USD Million)

Figure 30.        China: Rare Neurological Disease Treatment Market – Revenue and Forecast to 2027 (USD Million)

Figure 31.        Japan: Rare Neurological Disease Treatment Market – Revenue and Forecast to 2027 (USD Million)

Figure 32.        India: Rare Neurological Disease Treatment Market – Revenue and Forecast to 2027 (USD Million)

Figure 33.        South Korea: Rare Neurological Disease Treatment Market – Revenue and Forecast to 2027 (USD Million)

Figure 34.        Australia: Rare Neurological Disease Treatment Market – Revenue and Forecast to 2027 (USD Million)

Figure 35.        Impact of COVID-19 Pandemic In Asia Pacific Country Markets